{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:32:50Z","timestamp":1790854370480,"version":"4.1.0"},"reference-count":139,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Central serous chorioretinopathy (CSC) has remained an enigmatic disease since its initial description by Von Graefe. Over the years, multiple risk factors have been recognized: these include psychological stress, behavioral traits, and corticosteroids. The basic pathophysiology of CSC involves choroidal thickening, vascular congestion, altered choroidal blood flow (ChBF), and choroidal hyperpermeability, leading to retinal pigment epithelium decompensation and subsequent neurosensory detachment. Multiple organ systems, mainly the nervous, cardiovascular, endocrinal, and renal systems participate in the control of the vascular tone and the ChBF via hypothalamus\u2013pituitary\u2013adrenal axis and renin\u2013angiotensin\u2013aldosterone system, while others such as the hepatic system regulate the enzymatic degradation of corticosteroids. Many vasoactive and psychotropic drugs also modulate the ocular perfusion. In addition, there are anatomical and genetic predispositions that determine its progression to the chronic or recurrent form, through cellular response and angiogenesis. We herein review the basic pathophysiology and immunogenetics in CSC along with the role of multiple organ systems. With this background, we propose an etiological classification that should provide a framework for customized therapeutic interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/2211-5056.362601","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T01:58:06Z","timestamp":1670205486000},"page":"381-393","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Central serous chorioretinopathy"],"prefix":"10.4103","volume":"12","author":[{"given":"Manish","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sashwanthi","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elon H. C.","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20240830","first-page":"250","article-title":"Maculopathy a corticosteroid side-effect","volume":"14","author":"Jain","year":"1966","journal-title":"J All India Ophthalmol Soc"},{"key":"R2-2-20240830","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/bjo.68.5.329","article-title":"Central serous chorioretinopathy complicating systemic corticosteroid treatment","volume":"68","author":"Wakakura","year":"1984","journal-title":"Br J Ophthalmol"},{"key":"R3-2-20240830","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/IAE.0b013e31823ff9a6","article-title":"Type A behavior and central serous chorioretinopathy","volume":"32","author":"Yannuzzi","year":"2012","journal-title":"Retina"},{"key":"R4-2-20240830","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archopht.1994.01090200063023","article-title":"Digital indocyanine green videoangiography of central serous chorioretinopathy","volume":"112","author":"Guyer","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"R5-2-20240830","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1167\/iovs.05-1246","article-title":"Sympathetic-parasympathetic activity and reactivity in central serous chorioretinopathy: A case-control study","volume":"47","author":"Tewari","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R6-2-20240830","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00417-020-04940-0","article-title":"Pachychoroid: Current concepts on clinical features and pathogenesis","volume":"259","author":"Castro-Navarro","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R7-2-20240830","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1167\/iovs.11-7364","article-title":"Diurnal variations in axial length, choroidal thickness, intraocular pressure, and ocular biometrics","volume":"52","author":"Chakraborty","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R8-2-20240830","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1097\/IAE.0000000000000626","article-title":"Variations in choroidal thickness after high-dose systemic corticosteroid treatment in children with chronic glomerulonephritis","volume":"35","author":"Lee","year":"2015","journal-title":"Retina"},{"key":"R9-2-20240830","doi-asserted-by":"crossref","first-page":"e15421","DOI":"10.1097\/MD.0000000000015421","article-title":"Evaluation of changes in choroidal thickness and the choroidal vascularity index after hemodialysis in patients with end-stage renal disease by using swept-source optical coherence tomography","volume":"98","author":"Shin","year":"2019","journal-title":"Medicine (Baltimore"},{"key":"R10-2-20240830","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1111\/bcp.15237","article-title":"The effect of systemic and topical ophthalmic medications on choroidal thickness: A review","volume":"88","author":"Yeung","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"R11-2-20240830","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1080\/08164622.2021.1958653","article-title":"Choroidal and retinal thickness variations in anaemia and anaemic retinopathy","volume":"105","author":"Venkatesh","year":"2022","journal-title":"Clin Exp Optom"},{"key":"R12-2-20240830","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0002-9394(03)00076-X","article-title":"Central serous chorioretinopathy associated with administration of sympathomimetic agents","volume":"136","author":"Michael","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R13-2-20240830","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00006982-200110000-00030","article-title":"Central serous chorioretinopathy in a patient using methylenedioxymethamphetamine (MDMA) or \u201cecstasy\u201d","volume":"21","author":"Hassan","year":"2001","journal-title":"Retina"},{"key":"R14-2-20240830","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/ICB.0b013e31818ad3ce","article-title":"Central serous chorioretinopathy associated with the use of ephedra","volume":"3","author":"Pierce","year":"2009","journal-title":"Retin Cases Brief Rep"},{"key":"R15-2-20240830","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000309239","article-title":"Experimental central serous chorioretinopathy in monkey eyes: Fluorescein angiographic findings","volume":"185","author":"Yoshioka","year":"1982","journal-title":"Ophthalmologica"},{"key":"R16-2-20240830","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1167\/iovs.62.3.25","article-title":"Choroidal and retinal changes after systemic adrenaline and photodynamic therapy in non-human primates","volume":"62","author":"Cheong","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R17-2-20240830","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000485912","article-title":"Central serous chorioretinopathy associated with desmopressin nasal spray: Causality or unfortunate association","volume":"9","author":"Kisma","year":"2018","journal-title":"Case Rep Ophthalmol"},{"key":"R18-2-20240830","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/15569527.2011.613427","article-title":"Central chorioretinopathy associated with topical use of minoxidil 2% for treatment of baldness","volume":"31","author":"Scarinci","year":"2012","journal-title":"Cutan Ocul Toxicol"},{"key":"R19-2-20240830","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.survophthal.2021.06.004","article-title":"Sildenafil in ophthalmology: An update","volume":"67","author":"Arora","year":"2022","journal-title":"Surv Ophthalmol"},{"key":"R20-2-20240830","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/s41433-020-0995-9","article-title":"Effects of different mydriatics on the choroidal vascularity in healthy subjects","volume":"35","author":"Iovino","year":"2021","journal-title":"Eye (Lond"},{"key":"R21-2-20240830","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mehy.2018.02.024","article-title":"Clinical manifestations of pachychoroid may be secondary to pachysclera and increased scleral rigidity","volume":"113","author":"Venkatesh","year":"2018","journal-title":"Med Hypotheses"},{"key":"R22-2-20240830","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/IAE.0000000000003485","article-title":"Regional scleral thickness as a risk factor for central serous chorioretinopathy","volume":"42","author":"Spaide","year":"2022","journal-title":"Retina"},{"key":"R23-2-20240830","doi-asserted-by":"crossref","first-page":"100973","DOI":"10.1016\/j.preteyeres.2021.100973","article-title":"Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders","volume":"86","author":"Spaide","year":"2022","journal-title":"Prog Retin Eye Res"},{"key":"R25-2-20240830","first-page":"439","article-title":"Autonomic control of the eye","volume":"5","author":"McDougal","year":"2015","journal-title":"Compr Physiol"},{"key":"R26-2-20240830","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: Regulation and function","volume":"33","author":"F\u00f6rstermann","year":"2012","journal-title":"Eur Heart J"},{"key":"R27-2-20240830","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1167\/iovs.17-21825","article-title":"Peripheral vascular endothelial dysfunction in central serous chorioretinopathy","volume":"58","author":"Wang","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R28-2-20240830","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ajo.2006.03.031","article-title":"The role of serum endothelin-1 level in the etiopathogenesis of central serous chorioretinopathy","volume":"142","author":"T\u00fcrk\u00e7\u00fco\u011flu","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R29-2-20240830","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1167\/iovs.05-0268","article-title":"Choroidal hemodynamic changes during isometric exercise in patients with inactive central serous chorioretinopathy","volume":"46","author":"Tittl","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R30-2-20240830","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1167\/iovs.02-0855","article-title":"Effects of adrenomedullin on ocular hemodynamic parameters in the choroid and the ophthalmic artery","volume":"44","author":"Dorner","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R31-2-20240830","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1111\/aos.14547","article-title":"Altered plasma cytokine levels in acute and chronic central serous chorioretinopathy","volume":"99","author":"Karska-Basta","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"R32-2-20240830","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3129\/i09-105","article-title":"Central serous chorioretinopathy and idiopathic nonhistaminergic angioedema","volume":"44","author":"Edalati","year":"2009","journal-title":"Can J Ophthalmol"},{"key":"R33-2-20240830","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000050855","article-title":"Familial chronic central serous chorioretinopathy","volume":"215","author":"Weenink","year":"2001","journal-title":"Ophthalmologica"},{"key":"R34-2-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2007.03552.x","article-title":"Translational mini-review series on complement factor H: Genetics and disease associations of human complement factor H","volume":"151","author":"de C\u00f3rdoba","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"R35-2-20240830","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/jamaophthalmol.2018.3190","article-title":"Role of the complement system in chronic central serous chorioretinopathy: A genome-wide association study","volume":"136","author":"Schellevis","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"R36-2-20240830","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1097\/IAE.0000000000002682","article-title":"Genetic risk factors in severe, nonsevere and acute phenotypes of central serous chorioretinopathy","volume":"40","author":"Mohabati","year":"2020","journal-title":"Retina"},{"key":"R37-2-20240830","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/genes13010055","article-title":"Associations of single-nucleotide polymorphisms in Slovenian patients with acute central serous chorioretinopathy","volume":"13","author":"Kiraly","year":"2021","journal-title":"Genes (Basel"},{"key":"R38-2-20240830","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ophtha.2014.09.026","article-title":"Chronic central serous chorioretinopathy is associated with genetic variants implicated in age-related macular degeneration","volume":"122","author":"de Jong","year":"2015","journal-title":"Ophthalmology"},{"key":"R39-2-20240830","doi-asserted-by":"crossref","first-page":"783178","DOI":"10.3389\/fmed.2021.783178","article-title":"Comparison of intraocular cytokine levels of choroidal neovascularization secondary to different retinopathies","volume":"8","author":"Liu","year":"2021","journal-title":"Front Med (Lausanne"},{"key":"R40-2-20240830","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1001\/jamaophthalmol.2017.0245","article-title":"Association of a haplotype in the NR3C2 gene, encoding the mineralocorticoid receptor, with chronic central serous chorioretinopathy","volume":"135","author":"van Dijk","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"R41-2-20240830","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.1073\/pnas.1802212115","article-title":"CFH and VIPR2 as susceptibility loci in choroidal thickness and pachychoroid disease central serous chorioretinopathy","volume":"115","author":"Hosoda","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R42-2-20240830","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1152\/japplphysiol.01187.2009","article-title":"VIP\/PACAP receptor mediation of cutaneous active vasodilation during heat stress in humans","volume":"109","author":"Kellogg","year":"2010","journal-title":"J Appl Physiol (1985"},{"key":"R43-2-20240830","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1080\/15321819.2018.1529683","article-title":"Neuroimmune cross-talk in Helicobacter pylori infection: Analysis of substance P and vasoactive intestinal peptide expression in gastric enteric nervous system","volume":"39","author":"Sticlaru","year":"2018","journal-title":"J Immunoassay Immunochem"},{"key":"R44-2-20240830","doi-asserted-by":"crossref","first-page":"e60424","DOI":"10.1371\/journal.pone.0060424","article-title":"Alterations of choroidal blood flow regulation in young healthy subjects with complement factor H polymorphism","volume":"8","author":"Told","year":"2013","journal-title":"PLoS One"},{"key":"R45-2-20240830","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7150\/jgen.55545","article-title":"The genetic background of central serous chorioretinopathy: A review on central serous chorioretinopathy genes","volume":"9","author":"Giannopoulos","year":"2021","journal-title":"J Genomics"},{"key":"R46-2-20240830","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/humu.22551","article-title":"Cadherin 5 is regulated by corticosteroids and associated with central serous chorioretinopathy","volume":"35","author":"Schubert","year":"2014","journal-title":"Hum Mutat"},{"key":"R47-2-20240830","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1365-2265.2011.04247.x","article-title":"ACTH-induced cortisol release is related to the copy number of the C4B gene encoding the fourth component of complement in patients with non-functional adrenal incidentaloma","volume":"76","author":"B\u00e1nlaki","year":"2012","journal-title":"Clin Endocrinol (Oxf"},{"key":"R48-2-20240830","doi-asserted-by":"crossref","first-page":"20175","DOI":"10.1038\/s41598-020-77202-y","article-title":"Lipocalin 2 as a potential systemic biomarker for central serous chorioretinopathy","volume":"10","author":"Matet","year":"2020","journal-title":"Sci Rep"},{"key":"R49-2-20240830","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1167\/iovs.63.9.9","article-title":"An insertion variant in CRH confers an increased risk of central serous chorioretinopathy","volume":"63","author":"Jin","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R50-2-20240830","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1210\/clinem\/dgab670","article-title":"The cortisol response of male and female choroidal endothelial cells: Implications for central serous chorioretinopathy","volume":"107","author":"Brinks","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"R51-2-20240830","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/cxo.12125","article-title":"Cytokine levels of the aqueous humour in central serous chorioretinopathy","volume":"97","author":"Jung","year":"2014","journal-title":"Clin Exp Optom"},{"key":"R52-2-20240830","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3390\/medicina57101063","article-title":"Changes in plasma VEGF and PEDF levels in patients with central serous chorioretinopathy","volume":"57","author":"Chrz\u0105szcz","year":"2021","journal-title":"Medicina (Kaunas"},{"key":"R53-2-20240830","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.1167\/iovs.18-25517","article-title":"Association of upregulated angiogenic cytokines with choroidal abnormalities in chronic central serous chorioretinopathy","volume":"59","author":"Terao","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R54-2-20240830","doi-asserted-by":"crossref","first-page":"e12802","DOI":"10.1111\/jpi.12802","article-title":"Melatonin prevents experimental central serous chorioretinopathy in rats","volume":"73","author":"Yu","year":"2022","journal-title":"J Pineal Res"},{"key":"R55-2-20240830","doi-asserted-by":"crossref","first-page":"854","DOI":"10.4103\/ijo.IJO_1327_19","article-title":"Monocyte to high-density lipoprotein and neutrophil-to-lymphocyte ratios in patients with acute central serous chorioretinopathy","volume":"68","author":"Sirakaya","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"R56-2-20240830","doi-asserted-by":"crossref","first-page":"e15773","DOI":"10.1097\/MD.0000000000015773","article-title":"The concentration of tumor necrosis factor in the blood serum and in the urine and selected early organ damages in patients with primary systemic arterial hypertension","volume":"98","author":"Puszkarska","year":"2019","journal-title":"Medicine (Baltimore"},{"key":"R57-2-20240830","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/HYPERTENSIONAHA.111.173328","article-title":"Interleukin 6 underlies angiotensin II-induced hypertension and chronic renal damage","volume":"59","author":"Zhang","year":"2012","journal-title":"Hypertension"},{"key":"R58-2-20240830","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/aos.13445","article-title":"Antiretinal antibodies in central serous chorioretinopathy: Prevalence and clinical implications","volume":"96","author":"Ten Berge","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"R59-2-20240830","first-page":"235","article-title":"Differences in anti-endothelial and anti-retinal antibody titers: Implications for the pathohysiology of acute and chronic central serous chorioretinopathy","volume":"71","author":"Karska-Basta","year":"2020","journal-title":"J Physiol Pharmacol"},{"key":"R60-2-20240830","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ophtha.2003.09.024","article-title":"Risk factors for central serous chorioretinopathy: A case-control study","volume":"111","author":"Haimovici","year":"2004","journal-title":"Ophthalmology"},{"key":"R61-2-20240830","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4103\/0301-4738.179731","article-title":"Traumatic central serous chorioretinopathy in the fellow eye?","volume":"64","author":"Yu","year":"2016","journal-title":"Indian J Ophthalmol"},{"key":"R62-2-20240830","doi-asserted-by":"crossref","first-page":"bcr0120125626","DOI":"10.1136\/bcr.01.2012.5626","article-title":"Central serous chorioretinopathy after blunt trauma?","volume":"2012","author":"Ponce","year":"2012","journal-title":"BMJ Case Rep"},{"key":"R63-2-20240830","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.spen.2004.04.001","article-title":"Cerebral pathophysiology and critical care neurology: basic hemodynamic principles, cerebral perfusion, and intracranial pressure","volume":"11","author":"Smith","year":"2004","journal-title":"Semin Pediatr Neurol"},{"key":"R64-2-20240830","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.mehy.2013.04.032","article-title":"Getting serious with retinopathy: Approaching an integrated hypothesis for central serous chorioretinopathy","volume":"81","author":"Bujarborua","year":"2013","journal-title":"Med Hypotheses"},{"key":"R65-2-20240830","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.pnpbp.2005.08.006","article-title":"Limbic system mechanisms of stress regulation: Hypothalamo-pituitary-adrenocortical axis","volume":"29","author":"Herman","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R66-2-20240830","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12177-009-9028-4","article-title":"Psychoneuroimmunology: Application to ocular diseases","volume":"2","author":"Ventura","year":"2009","journal-title":"J Ocul Biol Dis Infor"},{"key":"R67-2-20240830","doi-asserted-by":"crossref","first-page":"631687","DOI":"10.1155\/2014\/631687","article-title":"Temperament and character personality profile and illness-related stress in central serous chorioretinopathy","volume":"2014","author":"Conrad","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"R68-2-20240830","first-page":"1131","article-title":"In patients suffering from idiopathic central serous chorioretinopathy, anxiety scores are higher than in healthy controls, but do not vary according to sex or repeated central serous chorioretinopathy","volume":"11","author":"Bazzazi","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R69-2-20240830","doi-asserted-by":"crossref","first-page":"2749296","DOI":"10.1155\/2019\/2749296","article-title":"Association between central serous chorioretinopathy and risk of depression: A population-based cohort study","volume":"2019","author":"Chen","year":"2019","journal-title":"J Ophthalmol"},{"key":"R70-2-20240830","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ajo.2016.02.012","article-title":"Shift work: A risk factor for central serous chorioretinopathy","volume":"165","author":"Bousquet","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"R71-2-20240830","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.smrv.2007.07.007","article-title":"Restricted and disrupted sleep: Effects on autonomic function, neuroendocrine stress systems and stress responsivity","volume":"12","author":"Meerlo","year":"2008","journal-title":"Sleep Med Rev"},{"key":"R72-2-20240830","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1073\/pnas.0808180106","article-title":"Adverse metabolic and cardiovascular consequences of circadian misalignment","volume":"106","author":"Scheer","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R73-2-20240830","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s11325-017-1604-4","article-title":"A meta-analysis of obstructive sleep apnea in patients with cerebrovascular disease","volume":"22","author":"Wu","year":"2018","journal-title":"Sleep Breath"},{"key":"R74-2-20240830","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1080\/09286586.2021.1925306","article-title":"Relationship between obstructive sleep apnea and central serous chorioretinopathy: A health insurance database study","volume":"29","author":"Lee","year":"2022","journal-title":"Ophthalmic Epidemiol"},{"key":"R75-2-20240830","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1210\/jc.2009-1174","article-title":"Hypothalamic-pituitary-adrenal axis activation in obstructive sleep apnea: The effect of continuous positive airway pressure therapy","volume":"94","author":"Henley","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R76-2-20240830","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/PL00007893","article-title":"Epinephrine, but not dexamethasone, induces apoptosis in retinal pigment epithelium cells in vitro: Possible implications on the pathogenesis of central serous chorioretinopathy","volume":"238","author":"Sibayan","year":"2000","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R77-2-20240830","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/bjo.81.11.962","article-title":"Endogenous cortisol profile in patients with central serous chorioretinopathy","volume":"81","author":"Garg","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"R78-2-20240830","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00417-006-0253-2","article-title":"Prehypertension may be common in patients with central serous chorioretinopathy","volume":"244","author":"Venkatesh","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R79-2-20240830","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0002-9394(99)00075-6","article-title":"Systemic findings associated with central serous chorioretinopathy","volume":"128","author":"Tittl","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"R80-2-20240830","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/IAE.0000000000000837","article-title":"Risk factors for central serous chorioretinopathy: A systematic review and meta-analysis","volume":"36","author":"Liu","year":"2016","journal-title":"Retina"},{"key":"R81-2-20240830","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/bjophthalmol-2013-303945","article-title":"Increased risk of coronary heart disease in male patients with central serous chorioretinopathy: Results of a population-based cohort study","volume":"98","author":"Chen","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"R82-2-20240830","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1136\/bjophthalmol-2012-301810","article-title":"Central serous chorioretinopathy and risk of ischaemic stroke: A population-based cohort study","volume":"96","author":"Tsai","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"R83-2-20240830","doi-asserted-by":"crossref","first-page":"E5099","DOI":"10.3390\/ijerph16245099","article-title":"The correlation of central serous chorioretinopathy and subsequent cardiovascular diseases of different types: A population-based cohort study","volume":"16","author":"Hsu","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"R84-2-20240830","first-page":"3717","article-title":"Impact of hypertension on choroidal thickness in central serous chorioretinopathy","volume":"56","author":"Boonarpha","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R85-2-20240830","doi-asserted-by":"crossref","first-page":"6652373","DOI":"10.1155\/2021\/6652373","article-title":"Intima-media thickness measurements of the common carotid artery in patients with central serous chorioretinopathy: A case-control study","volume":"2021","author":"Nasrollahi","year":"2021","journal-title":"J Ophthalmol"},{"key":"R86-2-20240830","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s004170050123","article-title":"Assessment of the sympatho-vagal interaction in central serous chorioretinopathy measured by power spectral analysis of heart rate variability","volume":"236","author":"Bernasconi","year":"1998","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R87-2-20240830","doi-asserted-by":"crossref","first-page":"324","DOI":"10.5935\/0034-7280.20180070","article-title":"Autonomic dysfunction in patients with central serous chorioretinopathy","volume":"77","author":"Bezerra","year":"2018","journal-title":"Rev Bras Oftalmol"},{"key":"R88-2-20240830","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1038\/s41433-020-01222-1","article-title":"A new potential risk factor for central serous chorioretinopathy: Blood pressure variability","volume":"35","author":"Karada\u011f","year":"2021","journal-title":"Eye (Lond"},{"key":"R89-2-20240830","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/JCMA.0000000000000207","article-title":"Relationship between heart failure and central serous chorioretinopathy: A cohort study in Taiwan","volume":"82","author":"Huang","year":"2019","journal-title":"J Chin Med Assoc"},{"key":"R90-2-20240830","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI61427","article-title":"Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy","volume":"122","author":"Zhao","year":"2012","journal-title":"J Clin Invest"},{"key":"R91-2-20240830","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3357\/ASEM.4073.2014","article-title":"Central serous chorioretinopathy following hypobaric chamber exposure","volume":"85","author":"Ide","year":"2014","journal-title":"Aviat Space Environ Med"},{"key":"R92-2-20240830","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/bjo.87.6.709","article-title":"Features of abnormal choroidal circulation in central serous chorioretinopathy","volume":"87","author":"Kitaya","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"R93-2-20240830","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/IAE.0000000000000796","article-title":"Risk of retinal vein occlusion with central serous chorioretinopathy","volume":"36","author":"Chang","year":"2016","journal-title":"Retina"},{"key":"R94-2-20240830","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.jfo.2021.10.001","article-title":"Bilateral central serous chorioretinopathy post-COVID-19","volume":"44","author":"Mahjoub","year":"2021","journal-title":"J Fr Ophtalmol"},{"key":"R95-2-20240830","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/kjm2.12473","article-title":"Disc edema in one eye and central serous chorioretinopathy in the other eye shortly after AstraZeneca COVID-19 vaccination","volume":"38","author":"Lee","year":"2022","journal-title":"Kaohsiung J Med Sci"},{"key":"R96-2-20240830","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jfo.2022.02.001","article-title":"Bilateral multifocal central serous retinopathy following mRNA COVID-19 vaccine","volume":"45","author":"Mechleb","year":"2022","journal-title":"J Fr Ophtalmol"},{"key":"R97-2-20240830","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jfo.2022.01.006","article-title":"Central serous chorioretinopathy following the BNT162b2 mRNA vaccine","volume":"45","author":"Hanhart","year":"2022","journal-title":"J Fr Ophtalmol"},{"key":"R98-2-20240830","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/archopht.1993.01090090081024","article-title":"Central serous chorioretinopathy in endogenous hypercortisolism","volume":"111","author":"Bouzas","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"R99-2-20240830","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1007\/s00417-016-3417-8","article-title":"Central serous chorioretinopathy in primary hyperaldosteronism","volume":"254","author":"van Dijk","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R101-2-20240830","doi-asserted-by":"crossref","first-page":"e14859","DOI":"10.1097\/MD.0000000000014859","article-title":"Increased risk of central serous chorioretinopathy following end-stage renal disease: A nationwide population-based study","volume":"98","author":"Chang","year":"2019","journal-title":"Medicine (Baltimore"},{"key":"R102-2-20240830","doi-asserted-by":"crossref","first-page":"20A","DOI":"10.1016\/j.amjcard.2005.11.012","article-title":"Inflammation in renal disease","volume":"97","author":"Vidt","year":"2006","journal-title":"Am J Cardiol"},{"key":"R103-2-20240830","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1681\/ASN.2007030355","article-title":"Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD","volume":"19","author":"Ramos","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R104-2-20240830","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1097\/IAE.0b013e31820a69ee","article-title":"Central serous chorioretinopathy after renal transplantation","volume":"31","author":"Lee","year":"2011","journal-title":"Retina"},{"key":"R105-2-20240830","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1007\/s00417-017-3823-6","article-title":"Spectrum of retinal abnormalities in renal transplant patients using chronic low-dose steroids","volume":"255","author":"van Dijk","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R106-2-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2017.06.008","article-title":"Central serous chorioretinopathy and glucocorticoids: An update on evidence for association","volume":"63","author":"Nicholson","year":"2018","journal-title":"Surv Ophthalmol"},{"key":"R107-2-20240830","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000054384","article-title":"Mineralocorticoid receptor also modulates basal activity of hypothalamus-pituitary-adrenocortical system in humans","volume":"68","author":"Deuschle","year":"1998","journal-title":"Neuroendocrinology"},{"key":"R108-2-20240830","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3390\/ijms23031278","article-title":"Chronic systemic dexamethasone regulates the mineralocorticoid\/glucocorticoid pathways balance in rat ocular tissues","volume":"23","author":"Zola","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R109-2-20240830","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/hr.2012.4","article-title":"Hormonal effects on blood vessels","volume":"35","author":"Akishita","year":"2012","journal-title":"Hypertens Res"},{"key":"R110-2-20240830","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1476-5381.2012.02194.x","article-title":"Aldosterone affects blood flow and vascular tone regulated by endothelium-derived no: Therapeutic implications","volume":"168","author":"Toda","year":"2013","journal-title":"Br J Pharmacol"},{"key":"R111-2-20240830","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fendo.2018.00066","article-title":"Gonadal hormones and retinal disorders: A review","volume":"9","author":"Nuzzi","year":"2018","journal-title":"Front Endocrinol (Lausanne"},{"key":"R112-2-20240830","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00006842-198405000-00004","article-title":"Elevated daytime urinary excretion of testosterone glucuronide in men with the type a behavior pattern","volume":"46","author":"Zumoff","year":"1984","journal-title":"Psychosom Med"},{"key":"R113-2-20240830","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3928\/23258160-20141118-16","article-title":"Bilateral central serous chorioretinopathy associated with estrogen modulator diindolylmethane","volume":"45","author":"Bussel","year":"2014","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R114-2-20240830","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0161-6420(96)30730-6","article-title":"Central serous chorioretinopathy in women","volume":"103","author":"Quillen","year":"1996","journal-title":"Ophthalmology"},{"key":"R115-2-20240830","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/archopht.1993.01090030078043","article-title":"Central serous chorioretinopathy and pregnancy","volume":"111","author":"Sunness","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"R116-2-20240830","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2265.1990.tb00492.x","article-title":"Diurnal salivary cortisol patterns during pregnancy and after delivery: Relationship to plasma corticotrophin-releasing-hormone","volume":"33","author":"Allolio","year":"1990","journal-title":"Clin Endocrinol (Oxf"},{"key":"R117-2-20240830","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3928\/23258160-20150610-16","article-title":"Polycystic ovary syndrome and central serous chorioretinopathy","volume":"46","author":"Witmer","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R118-2-20240830","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/ICB.0000000000000298","article-title":"Central serous chorioretinopathy in postmenopausal women receiving exogenous testosterone","volume":"11","author":"Conway","year":"2017","journal-title":"Retin Cases Brief Rep"},{"key":"R119-2-20240830","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00417-018-3985-x","article-title":"The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels","volume":"256","author":"\u00c7ilo\u011flu","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R120-2-20240830","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2147\/TCRM.S370133","article-title":"The association between circulating sex hormones and central serous chorioretinopathy: A case-control study","volume":"18","author":"Zhao","year":"2022","journal-title":"Ther Clin Risk Manag"},{"key":"R121-2-20240830","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-2003-38187","article-title":"Central serous chorioretinopathy associated with adrenal myelolipoma","volume":"220","author":"Katsimpris","year":"2003","journal-title":"Klin Monbl Augenheilkd"},{"key":"R122-2-20240830","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00006982-200001000-00020","article-title":"Central serous chorioretinopathy associated with a carcinoma of the adrenal cortex","volume":"20","author":"Thoelen","year":"2000","journal-title":"Retina"},{"key":"R123-2-20240830","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000333556","article-title":"Adrenocortical adenoma and central serous chorioretinopathy: A rare association?","volume":"2","author":"Pastor-Idoate","year":"2011","journal-title":"Case Rep Ophthalmol"},{"key":"R124-2-20240830","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cpcardiol.2015.04.002","article-title":"Thyroid disease and the heart","volume":"41","author":"Klein","year":"2016","journal-title":"Curr Probl Cardiol"},{"key":"R125-2-20240830","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/bjophthalmol-2018-312431","article-title":"Patient characteristics and risk factors for central serous chorioretinopathy: An analysis of 811 patients","volume":"103","author":"Ersoz","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"R126-2-20240830","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1756-6614-5-13","article-title":"Elevated thyroid stimulating hormone is associated with elevated cortisol in healthy young men and women","volume":"5","author":"Walter","year":"2012","journal-title":"Thyroid Res"},{"key":"R127-2-20240830","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/08820538.2019.1684524","article-title":"Can hypothyroidism cause acute central serous chorioretinopathy?","volume":"34","author":"Ula\u015f","year":"2019","journal-title":"Semin Ophthalmol"},{"key":"R128-2-20240830","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1210\/jcem-44-6-1185","article-title":"Catecholamine metabolism in thyroid disease. II. Norepinephrine secretion rate in hyperthyroidism and hypothyroidism","volume":"44","author":"Coulombe","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"R129-2-20240830","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.mehy.2018.10.003","article-title":"Autoimmune thyroiditis and central serous chorioretinopathy may have a relation","volume":"121","author":"Takkar","year":"2018","journal-title":"Med Hypotheses"},{"key":"R130-2-20240830","doi-asserted-by":"crossref","first-page":"49","DOI":"10.14797\/mdcj-13-2-49","article-title":"The parathyroid gland and heart disease","volume":"13","author":"Brown","year":"2017","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"R131-2-20240830","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.ajo.2004.01.054","article-title":"An association between central serous chorioretinopathy and gastroesophageal reflux disease","volume":"137","author":"Mansuetta","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R132-2-20240830","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1016\/j.crohns.2012.04.020","article-title":"A patient with ulcerative colitis and central serous chorioretinopathy \u2013 A therapeutic dilemma","volume":"7","author":"Geyshis","year":"2013","journal-title":"J Crohns Colitis"},{"key":"R133-2-20240830","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/IAE.0000000000000278","article-title":"Increased incidence of peptic ulcer disease in central serous chorioretinopathy patients: A population-based retrospective cohort study","volume":"35","author":"Chen","year":"2015","journal-title":"Retina"},{"key":"R134-2-20240830","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1161\/01.CIR.96.11.4095","article-title":"Roles of infectious agents in atherosclerosis and restenosis: An assessment of the evidence and need for future research","volume":"96","author":"Libby","year":"1997","journal-title":"Circulation"},{"key":"R135-2-20240830","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fendo.2018.00039","article-title":"Cushing's syndrome and hypothalamic-pituitary-adrenal axis hyperactivity in chronic central serous chorioretinopathy","volume":"9","author":"van Haalen","year":"2018","journal-title":"Front Endocrinol (Lausanne"},{"key":"R136-2-20240830","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/JCMA.0000000000000533","article-title":"Evaluation of the relationship between central serous chorioretinopathy and liver cirrhosis: A nationwide, population-based study","volume":"84","author":"Hsu","year":"2021","journal-title":"J Chin Med Assoc"},{"key":"R137-2-20240830","first-page":"299","article-title":"Central serous chorioretinopathy induced by drugs metabolized by cytochrome P450 3A4","volume":"71","author":"Morawski","year":"2020","journal-title":"J Physiol Pharmacol"},{"key":"R138-2-20240830","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4103\/0301-4738.16181","article-title":"Acute bilateral central serous chorioretinopathy following intra-articular injection of corticosteroid","volume":"53","author":"Mondal","year":"2005","journal-title":"Indian J Ophthalmol"},{"key":"R139-2-20240830","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5935\/0004-2749.20170003","article-title":"Frequency of fibromyalgia syndrome in patients with central serous chorioretinopathy","volume":"80","author":"Balkarli","year":"2017","journal-title":"Arq Bras Oftalmol"},{"key":"R140-2-20240830","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/IAE.0b013e31815ec2c8","article-title":"Central serous chorioretinopathy associated with sildenafil","volume":"28","author":"Fraunfelder","year":"2008","journal-title":"Retina"},{"key":"R141-2-20240830","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/eye.1999.67","article-title":"Central serous chorioretinopathy in a patient with cryoglobulinaemia","volume":"13","author":"Zamir","year":"1999","journal-title":"Eye (Lond"}],"container-title":["Taiwan Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/2211-5056.362601","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:17:20Z","timestamp":1787757440000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/2211-5056.362601"}},"subtitle":["Pathophysiology, systemic associations, and a novel etiological classification"],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":139,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/2211-5056.362601","relation":{},"ISSN":["2211-5056"],"issn-type":[{"value":"2211-5056","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}